Compared with Cotrimoxazole Nitroxoline Seems to Be a Better Option for the Treatment and Prophylaxis of Urinary Tract Infections Caused by Multidrug-Resistant Uropathogens: An In Vitro Study

The resistance of uropathogens to various antibiotics is increasing, but nitroxoline remains active in vitro against some relevant multidrug resistant uropathogenic bacteria. <i>E. coli</i> strains, which are among the most common uropathogens, are unanimously susceptible. Thus, nitroxol...

Full description

Bibliographic Details
Main Authors: Ulrich Dobrindt, Haleluya T. Wami, Torsten Schmidt-Wieland, Daniela Bertsch, Klaus Oberdorfer, Herbert Hof
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/10/6/645
_version_ 1797532200387739648
author Ulrich Dobrindt
Haleluya T. Wami
Torsten Schmidt-Wieland
Daniela Bertsch
Klaus Oberdorfer
Herbert Hof
author_facet Ulrich Dobrindt
Haleluya T. Wami
Torsten Schmidt-Wieland
Daniela Bertsch
Klaus Oberdorfer
Herbert Hof
author_sort Ulrich Dobrindt
collection DOAJ
description The resistance of uropathogens to various antibiotics is increasing, but nitroxoline remains active in vitro against some relevant multidrug resistant uropathogenic bacteria. <i>E. coli</i> strains, which are among the most common uropathogens, are unanimously susceptible. Thus, nitroxoline is an option for the therapy of urinary tract infections caused by multiresistant bacteria. Since nitroxoline is active against bacteria in biofilms, it will also be effective in patients with indwelling catheters or foreign bodies in the urinary tract. Cotrimoxazole, on the other hand, which, in principle, can also act on bacteria in biofilms, is frequently inactive against multiresistant uropathogens. Based on phenotypic resistance data from a large number of urine isolates, structural characterisation of an MDR plasmid of a recent ST131 uropathogenic <i>E. coli</i> isolate, and publicly available genomic data of resistant enterobacteria, we show that nitroxoline could be used instead of cotrimoxazole for intervention against MDR uropathogens. Particularly in uropathogenic <i>E. coli</i>, but also in other enterobacterial uropathogens, the frequent parallel resistance to different antibiotics due to the accumulation of multiple antibiotic resistance determinants on mobile genetic elements argues for greater consideration of nitroxoline in the treatment of uncomplicated urinary tract infections.
first_indexed 2024-03-10T10:55:46Z
format Article
id doaj.art-8ebdfd6995ec47d99b066442090baf47
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T10:55:46Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-8ebdfd6995ec47d99b066442090baf472023-11-21T21:52:38ZengMDPI AGAntibiotics2079-63822021-05-0110664510.3390/antibiotics10060645Compared with Cotrimoxazole Nitroxoline Seems to Be a Better Option for the Treatment and Prophylaxis of Urinary Tract Infections Caused by Multidrug-Resistant Uropathogens: An In Vitro StudyUlrich Dobrindt0Haleluya T. Wami1Torsten Schmidt-Wieland2Daniela Bertsch3Klaus Oberdorfer4Herbert Hof5Institut für Hygiene, Universitätsklinikum Münster, 48149 Münster, GermanyInstitut für Hygiene, Universitätsklinikum Münster, 48149 Münster, GermanyMVZ Labor Limbach und Kollegen, Im Breitspiel 16, 69126 Heidelberg, GermanyMVZ Labor Limbach und Kollegen, Im Breitspiel 16, 69126 Heidelberg, GermanyMVZ Labor Limbach und Kollegen, Im Breitspiel 16, 69126 Heidelberg, GermanyMVZ Labor Limbach und Kollegen, Im Breitspiel 16, 69126 Heidelberg, GermanyThe resistance of uropathogens to various antibiotics is increasing, but nitroxoline remains active in vitro against some relevant multidrug resistant uropathogenic bacteria. <i>E. coli</i> strains, which are among the most common uropathogens, are unanimously susceptible. Thus, nitroxoline is an option for the therapy of urinary tract infections caused by multiresistant bacteria. Since nitroxoline is active against bacteria in biofilms, it will also be effective in patients with indwelling catheters or foreign bodies in the urinary tract. Cotrimoxazole, on the other hand, which, in principle, can also act on bacteria in biofilms, is frequently inactive against multiresistant uropathogens. Based on phenotypic resistance data from a large number of urine isolates, structural characterisation of an MDR plasmid of a recent ST131 uropathogenic <i>E. coli</i> isolate, and publicly available genomic data of resistant enterobacteria, we show that nitroxoline could be used instead of cotrimoxazole for intervention against MDR uropathogens. Particularly in uropathogenic <i>E. coli</i>, but also in other enterobacterial uropathogens, the frequent parallel resistance to different antibiotics due to the accumulation of multiple antibiotic resistance determinants on mobile genetic elements argues for greater consideration of nitroxoline in the treatment of uncomplicated urinary tract infections.https://www.mdpi.com/2079-6382/10/6/645parallel resistanceresistance plasmidhorizontal gene transferprophylaxis of uncomplicated UTI
spellingShingle Ulrich Dobrindt
Haleluya T. Wami
Torsten Schmidt-Wieland
Daniela Bertsch
Klaus Oberdorfer
Herbert Hof
Compared with Cotrimoxazole Nitroxoline Seems to Be a Better Option for the Treatment and Prophylaxis of Urinary Tract Infections Caused by Multidrug-Resistant Uropathogens: An In Vitro Study
Antibiotics
parallel resistance
resistance plasmid
horizontal gene transfer
prophylaxis of uncomplicated UTI
title Compared with Cotrimoxazole Nitroxoline Seems to Be a Better Option for the Treatment and Prophylaxis of Urinary Tract Infections Caused by Multidrug-Resistant Uropathogens: An In Vitro Study
title_full Compared with Cotrimoxazole Nitroxoline Seems to Be a Better Option for the Treatment and Prophylaxis of Urinary Tract Infections Caused by Multidrug-Resistant Uropathogens: An In Vitro Study
title_fullStr Compared with Cotrimoxazole Nitroxoline Seems to Be a Better Option for the Treatment and Prophylaxis of Urinary Tract Infections Caused by Multidrug-Resistant Uropathogens: An In Vitro Study
title_full_unstemmed Compared with Cotrimoxazole Nitroxoline Seems to Be a Better Option for the Treatment and Prophylaxis of Urinary Tract Infections Caused by Multidrug-Resistant Uropathogens: An In Vitro Study
title_short Compared with Cotrimoxazole Nitroxoline Seems to Be a Better Option for the Treatment and Prophylaxis of Urinary Tract Infections Caused by Multidrug-Resistant Uropathogens: An In Vitro Study
title_sort compared with cotrimoxazole nitroxoline seems to be a better option for the treatment and prophylaxis of urinary tract infections caused by multidrug resistant uropathogens an in vitro study
topic parallel resistance
resistance plasmid
horizontal gene transfer
prophylaxis of uncomplicated UTI
url https://www.mdpi.com/2079-6382/10/6/645
work_keys_str_mv AT ulrichdobrindt comparedwithcotrimoxazolenitroxolineseemstobeabetteroptionforthetreatmentandprophylaxisofurinarytractinfectionscausedbymultidrugresistanturopathogensaninvitrostudy
AT haleluyatwami comparedwithcotrimoxazolenitroxolineseemstobeabetteroptionforthetreatmentandprophylaxisofurinarytractinfectionscausedbymultidrugresistanturopathogensaninvitrostudy
AT torstenschmidtwieland comparedwithcotrimoxazolenitroxolineseemstobeabetteroptionforthetreatmentandprophylaxisofurinarytractinfectionscausedbymultidrugresistanturopathogensaninvitrostudy
AT danielabertsch comparedwithcotrimoxazolenitroxolineseemstobeabetteroptionforthetreatmentandprophylaxisofurinarytractinfectionscausedbymultidrugresistanturopathogensaninvitrostudy
AT klausoberdorfer comparedwithcotrimoxazolenitroxolineseemstobeabetteroptionforthetreatmentandprophylaxisofurinarytractinfectionscausedbymultidrugresistanturopathogensaninvitrostudy
AT herberthof comparedwithcotrimoxazolenitroxolineseemstobeabetteroptionforthetreatmentandprophylaxisofurinarytractinfectionscausedbymultidrugresistanturopathogensaninvitrostudy